Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Inventory (2016 - 2026)

Mimedx's Inventory history spans 17 years, with the latest figure at $26.2 million for Q1 2026.

  • On a quarterly basis, Inventory rose 8.97% to $26.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $26.2 million, a 8.97% increase, with the full-year FY2025 number at $25.3 million, up 6.44% from a year prior.
  • Inventory hit $26.2 million in Q1 2026 for Mimedx, up from $25.3 million in the prior quarter.
  • Over the last five years, Inventory for MDXG hit a ceiling of $26.5 million in Q3 2025 and a floor of $13.2 million in Q1 2022.
  • Historically, Inventory has averaged $20.6 million across 5 years, with a median of $23.8 million in 2024.
  • Biggest five-year swings in Inventory: surged 66.84% in 2024 and later fell 1.57% in 2025.
  • Tracing MDXG's Inventory over 5 years: stood at $13.2 million in 2022, then surged by 59.46% to $21.0 million in 2023, then rose by 13.25% to $23.8 million in 2024, then grew by 6.44% to $25.3 million in 2025, then grew by 3.5% to $26.2 million in 2026.
  • Business Quant data shows Inventory for MDXG at $26.2 million in Q1 2026, $25.3 million in Q4 2025, and $26.5 million in Q3 2025.